Literature DB >> 7556958

Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor.

S Gremlich1, A Porret, E H Hani, D Cherif, N Vionnet, P Froguel, B Thorens.   

Abstract

Glucose-dependent insulinotropic polypeptide (GIP) is a hormone secreted by the endocrine K-cells from the duodenum that stimulates glucose-induced insulin secretion. Here, we present the molecular characterization of the human pancreatic islet GIP receptor. cDNA clones for the GIP receptor were isolated from a human pancreatic islet cDNA library. They encoded two different forms of the receptor, which differed by a 27-amino acid insertion in the COOH-terminal cytoplasmic tail. The receptor protein sequence was 81% identical to that of the rat GIP receptor. When expressed in Chinese hamster lung fibroblasts, both forms of the receptor displayed high-affinity binding for GIP (180 and 600 pmol/l). GIP binding was displaced by < 20% by 1 mumol/l glucagon, glucagon-like peptide (GLP-I)(7-36) amide, vasoactive intestinal peptide, and secretin. However exendin-4 and exendin-(9-39) at 1 mumol/l displaced binding by approximately 70 and approximately 100% at 10 mumol/l. GIP binding to both forms of the receptor induced a dose-dependent increase in intracellular cAMP levels (EC50 values of 0.6-0.8 nmol/l) but no elevation of cytoplasmic calcium concentrations. Interestingly, both exendin-4 and exendin-(9-39) were antagonists of the receptor, inhibiting GIP-induced cAMP formation by up to 60% when present at a concentration of 10 mumol/l. Finally, the physical and genetic chromosomal localization of the receptor gene was determined to be on 19q13.3, close to the ApoC2 gene. These data will help study the physiology and pathophysiology of the human GIP receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556958     DOI: 10.2337/diab.44.10.1202

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  31 in total

1.  Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors.

Authors:  Frédéric Preitner; Mark Ibberson; Isobel Franklin; Christophe Binnert; Mario Pende; Asllan Gjinovci; Tanya Hansotia; Daniel J Drucker; Claes Wollheim; Rémy Burcelin; Bernard Thorens
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

2.  Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP.

Authors:  Oleg G Chepurny; Minos-Timotheos Matsoukas; George Liapakis; Colin A Leech; Brandon T Milliken; Robert P Doyle; George G Holz
Journal:  J Biol Chem       Date:  2019-01-08       Impact factor: 5.157

3.  Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.

Authors:  J Schirra; K Sturm; P Leicht; R Arnold; B Göke; M Katschinski
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

4.  Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength.

Authors:  A Mieczkowska; S Mansur; B Bouvard; P R Flatt; B Thorens; N Irwin; D Chappard; G Mabilleau
Journal:  Osteoporos Int       Date:  2014-08-16       Impact factor: 4.507

5.  GLP-1 receptor plays a critical role in geniposide-induced expression of heme oxygenase-1 in PC12 cells.

Authors:  Fei Yin; Jian-hui Liu; Xu-xu Zheng; Li-xia Guo
Journal:  Acta Pharmacol Sin       Date:  2010-04-05       Impact factor: 6.150

6.  Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.

Authors:  V A Gault; F P M O'Harte; P Harriott; M H Mooney; B D Green; P R Flatt
Journal:  Diabetologia       Date:  2003-02-12       Impact factor: 10.122

Review 7.  The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.

Authors:  Daniela Regazzo; Mattia Barbot; Carla Scaroni; Nora Albiger; Gianluca Occhi
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

8.  Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic B-cells.

Authors:  E Renström; L Eliasson; P Rorsman
Journal:  J Physiol       Date:  1997-07-01       Impact factor: 5.182

9.  Calcium influx activates adenylyl cyclase 8 for sustained insulin secretion in rat pancreatic beta cells.

Authors:  Haiqiang Dou; Changhe Wang; Xi Wu; Lijun Yao; Xiaoyu Zhang; Sasa Teng; Huadong Xu; Bin Liu; Qihui Wu; Quanfeng Zhang; Meiqin Hu; Yeshi Wang; Li Wang; Yi Wu; Shujiang Shang; Xinjiang Kang; Lianghong Zheng; Jin Zhang; Matthieu Raoux; Jochen Lang; Qing Li; Jing Su; Xiao Yu; Liangyi Chen; Zhuan Zhou
Journal:  Diabetologia       Date:  2014-11-09       Impact factor: 10.122

10.  Gastric inhibitory peptide, serotonin, and glucagon are unexpected chloride secretagogues in the rectal gland of the skate (Leucoraja erinacea).

Authors:  Catherine A Kelley; Sarah E Decker; Patricio Silva; John N Forrest
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-19       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.